• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evolv Technology Reports Fourth Quarter Financial Results

    3/10/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology
    Get the next $EVLV alert in real time by email

    — Company Raises Outlook for 2026 — 

    • Q4'25 Revenue of $38.5 million, up 32% year-over-year
    • Q4'25 Ending ARR1 of $120.5 million, up 21% year-over-year
    • Q4'25 Net Income of $10.9 million, with Net Profit Margin of 28%
    • Q4'25 Adjusted EBITDA2 of $1.8 million, with Adjusted EBITDA Margin2 of 5%
    • Q4'25 Ending Cash, Cash Equivalents and Marketable Securities of $69.0 million, up $12.8 million sequentially

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the year ended December 31, 2025.

    "We are pleased to be reporting solid fourth quarter results, which capped a year of significant improvement across the Company," said John Kedzierski, President and Chief Executive Officer of Evolv Technology. "We continue to deliver advanced weapons screening capabilities at scale for more than 1,200 customers worldwide through a tightly integrated platform that combines proprietary hardware, real-world visitor data sets, and AI-driven software, delivered via long-term subscriptions that foster durable customer relationships and high-quality recurring revenue. Looking ahead, we believe AI-based weapons screening will continue to become increasingly prevalent, and we look forward to capitalizing on this still-nascent market opportunity to help make the world a safer place to live, work, learn, and play."

    Results for the Fourth Quarter of 2025

    Total revenue for the fourth quarter of 2025 was $38.5 million, an increase of 32% compared to $29.1 million for the fourth quarter of 2024. Revenue for the fourth quarter of 2025 was primarily driven by strong new customer additions and continued expansion of deployments across the existing customer base. Annual Recurring Revenue ("ARR")1 was $120.5 million at the end of fourth quarter of 2025, an increase of 21% compared to $99.4 million at the end of the fourth quarter of 2024. Net income for the fourth quarter of 2025 was $10.9 million, or $0.06 per basic share and $0.06 per diluted share, compared to net loss of $(15.7) million, or $(0.10) per basic and diluted share, in the fourth quarter of 2024. Adjusted earnings (loss)2 for the fourth quarter of 2025 was $(5.3) million, or $(0.03) per diluted share, compared to adjusted earnings (loss)2 of $(4.4) million, or $(0.03) per diluted share, for the fourth quarter of 2024. Adjusted EBITDA2 for the fourth quarter of 2025 was $1.8 million compared to $0.4 million in the fourth quarter of 2024. As of December 31, 2025, the Company had cash, cash equivalents and marketable securities of $69.0 million.

    Results for 2025

    Total revenue for the twelve months ended December 31, 2025 was $145.9 million, an increase of 40% compared to $103.9 million for the twelve months ended December 31, 2024. Net loss for the twelve months ended December 31, 2025 was $(33.1) million, or $(0.20) per basic and diluted share, compared to $(54.0) million, or $(0.34) per basic and diluted share, in the twelve months ended December 31, 2024. Adjusted earnings (loss)2 for the twelve months ended December 31, 2025 was $(16.8) million, or $(0.10) per diluted share, compared to adjusted earnings (loss)2 of $(35.3) million, or $(0.23) per diluted share, for the twelve months ended December 31, 2024. Adjusted EBITDA2 for the twelve months ended December 31, 2025 was $11.1 million compared to $(21.0) million in the twelve months ended December 31, 2024.

    The following table summarizes the breakdown of recurring and non-recurring revenue3 for each period presented:

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

    2025

     

    2024

     

    % Change

     

    2025

     

    2024

     

    % Change

    Recurring revenue

    $

    29,547

     

    $

    23,678

     

    25

    %

     

    $

    112,098

     

    $

    87,419

     

    28

    %

    Non-recurring revenue

     

    8,957

     

     

    5,422

     

    65

    %

     

     

    33,807

     

     

    16,446

     

    106

    %

    Total revenue

    $

    38,504

     

    $

    29,100

     

    32

    %

     

    $

    145,905

     

    $

    103,865

     

    40

    %

    The following table summarizes operating cash flows for each period presented:

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

    Net loss

    $

    (33,138

    )

     

    $

    (54,017

    )

    Adjustments to reconcile net loss to net cash provided by operating activities

     

    38,542

     

     

     

    22,504

     

    Changes in operating assets and liabilities

     

    13,265

     

     

     

    660

     

    Net cash provided by (used in) operating activities

    $

    18,669

     

     

    $

    (30,853

    )

    Company Comments on Outlook for 2026

    The Company today commented on its business outlook for 2026. The Company's outlook is based on the current indications for its business, which may change at any time. The Company expects total revenues in 2026 to be between $172 to $178 million, reflecting growth of approximately 18% to 22% year-over-year. The Company expects ending ARR at December 31, 2026 to increase to approximately $145 to $150 million, reflecting growth of approximately 20% to 25% year-over-year. The Company continues to expect ARR growth to exceed total revenue growth as previously disclosed changes to the Company's selling model and pricing continue to reshape contractual revenue recognition toward a higher mix of recurring revenue and reduced one-time revenue. The Company currently expects approximately 50% of the Company's new unit deployments in 2026 to be delivered under the Company's pure subscription model, with the remaining 50% deployed through the Company's purchase-subscription model. The Company expects to deliver positive full year Adjusted EBITDA1 in 2026 with Adjusted EBITDA1 margins in the high single digits.

    Estimate

     

    Issued November 13, 2025

     

    Issued March 10, 2026

    Total Revenue (Millions)

    $160-$165

    $172-$178

    Ending ARR at 12/31/26 (Millions)

     

    n/a

     

    $145-$150

    Adjusted EBITDA Margin2

     

    n/a

     

    High Single Digits

    Company to Host Live Conference Call and Webcast

    The Company's management team plans to host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com.

    About Evolv Technology

    Evolv Technologies Holdings, Inc (NASDAQ:EVLV) is designed to transform human security to make a safer, faster, and better experience for the world's most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered screening and analytics. Its mission is to transform security to create a safer world to live, work, learn, and play. Evolv has digitally transformed the gateways in many places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv's advanced systems have scanned more than four billion people since 2019. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) 2024 New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category, as well as Sport Business Journal's (SBJ) 2024 awards for "Best In Fan Experience Technology" and "Best In Sports Technology". Evolv®, Evolv Express®, Evolv Insights®, Evolv Visual Gun Detection™, Evolv eXpedite™, and Evolv Eva™ are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit evolv.com.

    1 We define Annual Recurring Revenue, or ARR, as subscription revenue and the recurring service revenue related to purchase subscriptions for the final month of the quarter normalized to a one-year period. Our calculation of ARR is not adjusted for the impact of any known or projected future events (such as customer cancellations, upgrades or downgrades, or price increases or decreases) that may cause any such contract not to be renewed on its existing terms. In addition, the amount of actual revenue that we recognize over any 12-month period is likely to differ from ARR at the beginning of that period, sometimes significantly. This may occur due to new bookings, cancellations, upgrades, downgrades or other changes in pending renewals, as well as the effects of professional services revenue and acquisitions or divestitures. As a result, ARR should be viewed independently of, and not as a substitute for or forecast of, revenue and deferred revenue. Our calculation of ARR may differ from similarly titled metrics presented by other companies.

    2 Non-GAAP Financial Measures In this press release, the Company's adjusted gross profit (loss), adjusted gross margin, adjusted operating expenses, adjusted operating income (loss), adjusted EBITDA, adjusted EBITDA margin, adjusted earnings (loss), and adjusted earnings (loss) per diluted share are not presented in accordance with generally accepted accounting principles (GAAP) and are not intended to be used in lieu of GAAP presentations of results of operations. Adjusted gross profit and adjusted gross margin exclude stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, and non-recurring inventory charges, which management believes provides a more meaningful representation of contribution margin. Adjusted operating expenses is defined as operating expenses less stock-based compensation expense, loss on impairment of leased equipment, non-recurring employee restructuring and other separation costs, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of on-going operating expense levels. Other non-recurring legal and regulatory costs include non-recurring legal, accounting and professional fees related to the internal investigation, subsequent restatement, certain non-recurring regulatory, litigation and legal matters, as well as fees related to the resolution of the Securities and Exchange Commission investigation, net of estimated insurance recoveries. Adjusted operating income (loss), is defined as loss from operations, excluding stock-based compensation expense, amortization of capitalized stock-based compensation, loss on impairment of leased equipment, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted EBITDA and Adjusted EBITDA margin is defined as net income (loss) plus depreciation and amortization, stock-based compensation, interest expense (income), provision for income taxes, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on impairment of intangible asset, loss on disposal of leased equipment, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Adjusted earnings (loss) and Adjusted earnings (loss) per diluted share are defined as net income (loss) plus stock-based compensation, amortization of capitalized stock-based compensation, change in fair value of contingent earn-out liability, change in fair value of contingently issuable common stock liability, change in fair value of public warrant liability, loss on impairment of leased equipment, loss on impairment of intangible asset, non-recurring employee restructuring and other separation costs, non-recurring inventory charges, and other non-recurring legal and regulatory costs, which management believes provides a more meaningful representation of operating results. Management presents non-GAAP financial measures because it considers them to be important supplemental measures of performance. Management uses non-GAAP financial measures for planning purposes, including analysis of the Company's performance against prior periods, the preparation of operating budgets and to determine appropriate levels of operating and capital investments. Management also believes non-GAAP financial measures provide additional insight for analysts and investors in evaluating the Company's financial and operating performance. However, non-GAAP financial measures have limitations as an analytical tool and are not intended to be an alternative to financial measures prepared in accordance with GAAP. We intend to provide non-GAAP financial measures as part of our future earnings discussions and, therefore, the inclusion of non-GAAP financial measures will provide consistency in our financial reporting. Investors are encouraged to review the reconciliation of these non-GAAP measures to their most directly comparable GAAP financial measures included in this press release. The Company is unable to provide a reconciliation of Adjusted EBITDA to Net Income (Loss) and Adjusted EBITDA Margin to Net Profit Margin, each measure's most directly comparable GAAP financial measure, on a forward-looking basis without unreasonable effort, because items that impact these GAAP financial measures are not within the Company's control and/or cannot be reasonably predicted. These items may include, but are not limited to, predicting forward-looking share-based compensation, changes in the fair value of contingent earn out liabilities, changes in the fair value of contingently issuable common stock liabilities and changes in fair value of public warrant liabilities. Such information may have a significant, and potentially unpredictable, impact on the Company's future financial results.

    3 Recurring revenue includes the recurring portion of revenue associated with pure subscription contracts and hardware purchase subscription contracts. Non-recurring revenue includes revenue that is non-recurring in nature, such as product revenue, shipping revenue, and revenue from installation, training, and professional services.

    Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release and related presentation materials other than statements of historical facts, including without limitation statements regarding our strategy, goals, demand for our products, market opportunities, and future financial and operational results. Words such as "believe" "may," "will," "expect," "should," "could," "anticipate," "aim," "estimate," "intend," "plan," "potential," "continue," "project," "target," "forecast", "is/are likely to" or the negative of these terms or other similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. The forward-looking statements in this press release and related presentation materials are only predictions. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the amount of insurance reimbursements expected to be received for defense costs for counsel and consultants in connection with the securities litigation and related Securities and Exchange Commission (the "SEC") and Department of Justice matters, and the following: our history of losses and ability to reach profitability; our reliance on reseller partners; expectations regarding the Company's strategies and future financial performance, including its future business plans or objectives, prospective performance and opportunities and competitors, revenues, products and services, pricing, operating expenses, market trends, liquidity, cash flows and uses of cash, capital expenditures; our ability to renew customer contracts, our ability to renew customer contracts at terms favorable to the Company, the Company's reliance on third party contract manufacturing and distribution, and a global supply chain; the Company recognizes a substantial portion of its revenue ratably over the term of its agreements, and, as a result, downturns or upturns in sales may not be immediately reflected in its operating results; the rate of innovation required to maintain competitiveness in the markets in which the Company competes; the competitiveness of the market in which the Company competes; the failure of our products to detect threats could result in injury or loss of life, which could harm our brand, reputation, and results of operations; the loss of designation of our Evolv Express® system as a Qualified Anti-Terrorism Technology under the Homeland Security SAFETY Act; risks related to our business model, which is predicated, in part, on building a customer base that will generate a recurring stream of revenues through the sale of our subscription contracts; the ability for the Company to obtain, maintain, protect and enforce the Company's intellectual property rights and use of "open source" software; the concentration of the Company's revenues on a single solution; the Company's ability to timely design, produce and launch its solutions, the Company's ability to invest in growth initiatives and pursue acquisition opportunities; the limited liquidity and trading of the Company's securities; risks related to existing and changing tax laws; geopolitical risk and changes in applicable laws or regulations; the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; operational risk; risks related to material weaknesses in our internal control over financial reporting and our remediation plans; risks related to increasing attention to and evolving expectations for sustainability initiatives; the impact of fluctuating general economic and market conditions and reductions in spending; the need for additional capital to support business growth, which might not be available on acceptable terms, if at all; and litigation and regulatory enforcement risks, including the diversion of management time and attention and the additional costs and demands on resources. These and other important factors discussed in our most recent report on Form 10-Q or 10-K filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. The forward-looking statements in this press release and related presentation materials are based upon information available to us as of the date hereof, and while we believe such information forms a reasonable basis for such statements, it may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

    You should review this press release and the documents that we reference in this press release and related presentation materials with the understanding that our actual future results, levels of activity, performance and achievements may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained in this press release and related presentation materials, whether as a result of any new information, future events or otherwise.

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue:

     

     

     

     

     

     

     

    Product revenue

    $

    7,545

     

     

    $

    1,675

     

     

    $

    21,637

     

     

    $

    6,464

     

    Subscription revenue

     

    21,717

     

     

     

    17,263

     

     

     

    83,839

     

     

     

    65,046

     

    Service revenue

     

    8,151

     

     

     

    6,564

     

     

     

    29,375

     

     

     

    23,467

     

    License fee and other revenue

     

    1,091

     

     

     

    3,598

     

     

     

    11,054

     

     

     

    8,888

     

    Total revenue

     

    38,504

     

     

     

    29,100

     

     

     

    145,905

     

     

     

    103,865

     

    Cost of revenue:

     

     

     

     

     

     

     

    Cost of product revenue

     

    7,825

     

     

     

    2,166

     

     

     

    24,320

     

     

     

    10,735

     

    Cost of subscription revenue

     

    8,971

     

     

     

    8,604

     

     

     

    36,684

     

     

     

    27,846

     

    Cost of service revenue

     

    2,657

     

     

     

    1,476

     

     

     

    8,410

     

     

     

    5,225

     

    Cost of license fee and other revenue

     

    423

     

     

     

    113

     

     

     

    1,189

     

     

     

    597

     

    Total cost of revenue

     

    19,876

     

     

     

    12,359

     

     

     

    70,603

     

     

     

    44,403

     

    Gross profit

     

    18,628

     

     

     

    16,741

     

     

     

    75,302

     

     

     

    59,462

     

    Operating expenses:

     

     

     

     

     

     

     

    Research and development

     

    5,412

     

     

     

    5,390

     

     

     

    20,619

     

     

     

    23,446

     

    Sales and marketing

     

    11,132

     

     

     

    13,455

     

     

     

    45,626

     

     

     

    60,637

     

    General and administrative

     

    10,069

     

     

     

    16,759

     

     

     

    54,858

     

     

     

    56,602

     

    Restructuring costs

     

    —

     

     

     

    —

     

     

     

    2,662

     

     

     

    860

     

    Loss on impairment of property and equipment

     

    —

     

     

     

    15

     

     

     

    —

     

     

     

    224

     

    Total operating expenses

     

    26,613

     

     

     

    35,619

     

     

     

    123,765

     

     

     

    141,769

     

    Loss from operations

     

    (7,985

    )

     

     

    (18,878

    )

     

     

    (48,463

    )

     

     

    (82,307

    )

    Other income, net:

     

     

     

     

     

     

     

    Interest expense

     

    (1,018

    )

     

     

    —

     

     

     

    (1,732

    )

     

     

    —

     

    Interest income

     

    487

     

     

     

    548

     

     

     

    1,536

     

     

     

    2,942

     

    Other income (expense), net

     

    (18

    )

     

     

    (50

    )

     

     

    99

     

     

     

    (83

    )

    Change in fair value of contingent earn-out liability

     

    10,138

     

     

     

    1,218

     

     

     

    12,435

     

     

     

    16,310

     

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    2,683

     

     

     

    311

     

     

     

    2,614

     

     

     

    2,529

     

    Change in fair value of public warrant liability

     

    6,595

     

     

     

    1,131

     

     

     

    435

     

     

     

    6,592

     

    Total other income, net

     

    18,867

     

     

     

    3,158

     

     

     

    15,387

     

     

     

    28,290

     

    Loss before income taxes

     

    10,882

     

     

     

    (15,720

    )

     

     

    (33,076

    )

     

     

    (54,017

    )

    Provision for income taxes

     

    —

     

     

     

    —

     

     

    $

    62

     

     

    $

    —

     

    Net income (loss)

    $

    10,882

     

     

    $

    (15,720

    )

     

    $

    (33,138

    )

     

    $

    (54,017

    )

    Net income (loss) income attributable to common stockholders – basic and diluted

    $

    10,810

     

     

    $

    (15,720

    )

     

    $

    (33,138

    )

     

    $

    (54,017

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding

     

     

     

     

     

     

     

    Basic

     

    174,625,931

     

     

     

    158,997,410

     

     

     

    168,419,211

     

     

     

    156,573,886

     

    Diluted

     

    189,125,126

     

     

     

    158,997,410

     

     

     

    168,419,211

     

     

     

    156,573,886

     

    Net income (loss) per share

     

     

     

     

     

     

     

    Basic

    $

    0.06

     

     

    $

    (0.10

    )

     

    $

    (0.20

    )

     

    $

    (0.34

    )

    Diluted

    $

    0.06

     

     

    $

    (0.10

    )

     

    $

    (0.20

    )

     

    $

    (0.34

    )

     

     

     

     

     

     

     

     

    Net income (loss)

    $

    10,882

     

     

    $

    (15,720

    )

     

    $

    (33,138

    )

     

    $

    (54,017

    )

    Other comprehensive (loss) income

     

     

     

     

     

     

     

    Cumulative translation adjustment

     

    (4

    )

     

     

    96

     

     

     

    (109

    )

     

     

    21

     

    Total other comprehensive (loss) income

     

    (4

    )

     

     

    96

     

     

     

    (109

    )

     

     

    21

     

    Total comprehensive income (loss)

    $

    10,878

     

     

    $

    (15,624

    )

     

    $

    (33,247

    )

     

    $

    (53,996

    )

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    December 31, 2025

     

    December 31, 2024

    Assets

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    49,150

     

     

    $

    37,015

     

    Marketable securities

     

    19,885

     

     

     

    14,927

     

    Accounts receivable, net

     

    30,841

     

     

     

    28,392

     

    Inventory

     

    9,317

     

     

     

    16,963

     

    Current portion of contract assets

     

    878

     

     

     

    799

     

    Current portion of commission asset

     

    6,062

     

     

     

    5,429

     

    Prepaid expenses and other current assets

     

    35,169

     

     

     

    17,921

     

    Total current assets

     

    151,302

     

     

     

    121,446

     

    Contract assets, noncurrent

     

    15

     

     

     

    657

     

    Commission asset, noncurrent

     

    7,867

     

     

     

    7,567

     

    Property and equipment, net

     

    127,522

     

     

     

    123,661

     

    Operating lease right-of-use assets

     

    12,303

     

     

     

    13,993

     

    Other assets

     

    5,400

     

     

     

    735

     

    Total assets

    $

    304,409

     

     

    $

    268,059

     

     

     

     

     

    Liabilities and Stockholders' Equity

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    9,770

     

     

    $

    10,492

     

    Accrued expenses and other current liabilities

     

    35,293

     

     

     

    19,508

     

    Current portion of deferred revenue

     

    74,924

     

     

     

    64,506

     

    Current portion of operating lease liabilities

     

    2,989

     

     

     

    2,203

     

    Total current liabilities

     

    122,976

     

     

     

    96,709

     

    Deferred revenue, noncurrent

     

    16,716

     

     

     

    20,266

     

    Long-term debt

     

    28,596

     

     

     

    —

     

    Operating lease liabilities, noncurrent

     

    10,654

     

     

     

    12,326

     

    Contingent earn-out liability, noncurrent

     

    374

     

     

     

    12,809

     

    Contingently issuable common stock liability, noncurrent

     

    1,809

     

     

     

    4,001

     

    Public warrant liability, noncurrent

     

    3,862

     

     

     

    4,297

     

    Total liabilities

     

    184,987

     

     

     

    150,408

     

     

     

     

     

    Stockholders' equity:

     

     

     

    Preferred stock, $0.0001 par value; 100,000,000 authorized at December 31, 2025 and December 31, 2024; no shares issued and outstanding at December 31, 2025 and December 31, 2024

     

    —

     

     

     

    —

     

    Common stock, $0.0001 par value; 1,100,000,000 shares authorized at December 31, 2025 and December 31, 2024; 175,399,488 and 159,602,069 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively

     

    18

     

     

     

    16

     

    Additional paid-in capital

     

    507,347

     

     

     

    472,331

     

    Accumulated other comprehensive loss

     

    (141

    )

     

     

    (32

    )

    Accumulated deficit

     

    (387,802

    )

     

     

    (354,664

    )

    Stockholders' equity

     

    119,422

     

     

     

    117,651

     

    Total liabilities and stockholders' equity

    $

    304,409

     

     

    $

    268,059

     

     

    EVOLV TECHNOLOGY

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited)

     

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

    Cash flows from operating activities:

     

     

     

    Net loss

    $

    (33,138

    )

     

    $

    (54,017

    )

    Adjustments to reconcile net loss to net cash provided by (used in) operating activities:

     

     

     

    Depreciation and amortization

     

    24,340

     

     

     

    17,375

     

    Write-off of inventory and change in inventory reserve

     

    2,891

     

     

     

    2,578

     

    Loss on impairment of property and equipment

     

    —

     

     

     

    224

     

    Loss on impairment of intangible asset

     

    —

     

     

     

    983

     

    Loss on disposal of property and equipment

     

    3,787

     

     

     

    —

     

    Stock-based compensation

     

    21,096

     

     

     

    24,756

     

    Non-cash interest expense

     

    482

     

     

     

    —

     

    (Accretion) amortization of (discount) premium on marketable securities, net of change in accrued interest

     

    (126

    )

     

     

    447

     

    Non-cash lease expense

     

    1,690

     

     

     

    1,420

     

    Change in allowance for expected credit losses

     

    (134

    )

     

     

    152

     

    Change in fair value of earn-out liability

     

    (12,435

    )

     

     

    (16,310

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (2,614

    )

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    (435

    )

     

     

    (6,592

    )

    Changes in operating assets and liabilities

     

     

     

    Accounts receivable

     

    (2,315

    )

     

     

    (6,997

    )

    Inventory

     

    9,118

     

     

     

    (7,852

    )

    Commission assets

     

    (933

    )

     

     

    (1,360

    )

    Contract assets

     

    563

     

     

     

    905

     

    Other assets

     

    750

     

     

     

    467

     

    Prepaid expenses and other current assets

     

    (22,577

    )

     

     

    (964

    )

    Accounts payable

     

    3,775

     

     

     

    192

     

    Deferred revenue

     

    6,868

     

     

     

    12,815

     

    Accrued expenses and other current liabilities

     

    18,902

     

     

     

    4,534

     

    Operating lease liability

     

    (886

    )

     

     

    (1,080

    )

    Net cash provided by (used in) operating activities

     

    18,669

     

     

     

    (30,853

    )

    Cash flows from investing activities:

     

     

     

    Development of internal-use software

     

    (5,627

    )

     

     

    (6,125

    )

    Purchases of property and equipment

     

    (31,367

    )

     

     

    (31,189

    )

    Purchases of marketable securities

     

    (39,388

    )

     

     

    (29,367

    )

    Proceeds from maturities of marketable securities

     

    34,556

     

     

     

    65,282

     

    Net cash used in investing activities

     

    (41,826

    )

     

     

    (1,399

    )

    Cash flows from financing activities:

     

     

     

    Proceeds from exercise of stock options

     

    9,085

     

     

     

    1,809

     

    Proceeds from long-term debt

     

    26,316

     

     

     

    —

     

    Net cash provided by financing activities

     

    35,401

     

     

     

    1,809

     

    Effect of exchange rate changes on cash and cash equivalents

     

    (109

    )

     

     

    21

     

    Net increase (decrease) in cash and cash equivalents

     

    12,135

     

     

     

    (30,422

    )

    Cash and cash equivalents

     

     

     

    Cash, cash equivalents, and restricted cash at beginning of period

     

    37,015

     

     

     

    67,437

     

    Cash and cash equivalents at end of period

    $

    49,150

     

     

    $

    37,015

     

     

    EVOLV TECHNOLOGY

    SUMMARY OF KEY OPERATING STATISTICS

    (Unaudited)

     

     

    Three Months Ended or as of,

    ($ in thousands)

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

    New customers

     

     

    53

     

     

    84

     

     

    52

     

     

    60

     

     

    54

     

     

    63

     

     

    62

     

     

    64

    Annual recurring revenue

     

    $

    79,192

     

    $

    87,011

     

    $

    93,676

     

    $

    99,351

     

    $

    105,990

     

    $

    110,516

     

    $

    117,200

     

    $

    120,467

    Recurring revenue

     

    $

    18,961

     

    $

    21,016

     

    $

    23,764

     

    $

    23,678

     

    $

    25,753

     

    $

    26,678

     

    $

    30,120

     

    $

    29,547

    The following table includes the Company's remaining performance obligations for the fiscal quarters from December 31, 2024 through September 30, 2025, which have been updated to reflect immaterial adjustments made as part of the Company's 2025 year end financial reporting process. These changes had no impact on the Company's statements of operations and comprehensive income (loss), balance sheets, or statements of cash flows for any periods presented.

     

    As of

    ($ in thousands)

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

    Remaining performance obligation (as reported)

     

    $

    266,704

     

     

    $

    261,233

     

     

    $

    275,451

     

     

    $

    298,560

     

     

    $

    293,589

    Adjustment

     

     

    (7,592

    )

     

     

    (8,444

    )

     

     

    (8,415

    )

     

     

    (8,829

    )

     

     

    —

    Remaining performance obligation (as adjusted)

     

    $

    259,112

     

     

    $

    252,789

     

     

    $

    267,036

     

     

    $

    289,731

     

     

    $

    293,589

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP OPERATING EXPENSES TO ADJUSTED OPERATING EXPENSES

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended,

     

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

     

     

    (Restated)

     

    (Restated)

     

     

     

     

     

     

     

     

     

     

     

     

    Operating expenses, GAAP

     

    $

    34,061

     

     

    $

    37,128

     

     

    $

    34,961

     

     

    $

    35,619

     

     

    $

    33,539

     

     

    $

    33,711

     

     

    $

    29,902

     

     

    $

    26,613

     

    Stock-based compensation

     

     

    (6,292

    )

     

     

    (7,254

    )

     

     

    (7,263

    )

     

     

    (3,159

    )

     

     

    (4,660

    )

     

     

    (5,265

    )

     

     

    (5,121

    )

     

     

    (5,006

    )

    Loss on impairment of leased equipment

     

     

    —

     

     

     

    —

     

     

     

    (209

    )

     

     

    (15

    )

     

     

    —

     

     

     

    —

     

     

     

    —

     

     

     

    —

     

    Non-recurring employee restructuring and other separation costs

     

     

    —

     

     

     

    (1,000

    )

     

     

    —

     

     

     

    (2,060

    )

     

     

    (2,137

    )

     

     

    (827

    )

     

     

    (6

    )

     

     

    —

     

    Other non-recurring legal and regulatory costs

     

     

    (476

    )

     

     

    (2,185

    )

     

     

    (2,339

    )

     

     

    (7,284

    )

     

     

    (3,561

    )

     

     

    (5,979

    )

     

     

    36

     

     

     

    2,225

     

    Adjusted operating expenses

     

    $

    27,293

     

     

    $

    26,689

     

     

    $

    25,150

     

     

    $

    23,101

     

     

    $

    23,181

     

     

    $

    21,640

     

     

    $

    24,811

     

     

    $

    23,832

     

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP GROSS PROFIT TO ADJUSTED GROSS PROFIT, GAAP GROSS MARGIN TO ADJUSTED GROSS MARGIN AND GAAP INCOME (LOSS) FROM OPERATIONS TO ADJUSTED OPERATING INCOME (LOSS)

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue

    $

    38,504

     

     

    $

    29,100

     

     

    $

    145,905

     

     

    $

    103,865

     

    Cost of revenue

     

    19,876

     

     

     

    12,359

     

     

     

    70,603

     

     

     

    44,403

     

    Gross profit, GAAP

     

    18,628

     

     

     

    16,741

     

     

     

    75,302

     

     

     

    59,462

     

    Stock-based compensation

     

    274

     

     

     

    233

     

     

     

    1,044

     

     

     

    788

     

    Amortization of capitalized stock-based compensation

     

    150

     

     

     

    85

     

     

     

    474

     

     

     

    137

     

    Loss on impairment of intangible asset

     

    —

     

     

     

    983

     

     

     

    —

     

     

     

    983

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    —

     

     

     

    6

     

     

     

    —

     

    Non-recurring inventory charges

     

    —

     

     

     

    123

     

     

     

    —

     

     

     

    2,730

     

    Adjusted gross profit*

    $

    19,052

     

     

    $

    18,165

     

     

    $

    76,826

     

     

    $

    64,100

     

     

     

     

     

     

     

     

     

    Gross margin %

     

    48.4

    %

     

     

    57.5

    %

     

     

    51.6

    %

     

     

    57.2

    %

    Adjusted gross margin %

     

    49.5

    %

     

     

    62.4

    %

     

     

    52.7

    %

     

     

    61.7

    %

    *Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Loss from operations, GAAP

    $

    (7,985

    )

     

    $

    (18,878

    )

     

    $

    (48,463

    )

     

    $

    (82,307

    )

    Stock-based compensation

     

    5,280

     

     

     

    3,392

     

     

     

    21,096

     

     

     

    24,756

     

    Amortization of capitalized stock-based compensation

     

    150

     

     

     

    85

     

     

     

    474

     

     

     

    137

     

    Loss on impairment of leased equipment

     

    —

     

     

     

    15

     

     

     

    —

     

     

     

    224

     

    Loss on impairment of intangible asset

     

    —

     

     

     

    983

     

     

     

    —

     

     

     

    983

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,060

     

     

     

    2,976

     

     

     

    3,060

     

    Non-recurring inventory charges

     

    —

     

     

     

    123

     

     

     

    —

     

     

     

    2,730

     

    Other non-recurring legal and regulatory costs

     

    (2,225

    )

     

     

    7,284

     

     

     

    7,279

     

     

     

    12,284

     

    Adjusted loss from operations*

    $

    (4,780

    )

     

    $

    (4,936

    )

     

    $

    (16,638

    )

     

    $

    (38,133

    )

    *Beginning in the three month period ended September 30, 2025, and on a go-forward basis, management has determined that the loss on disposal of leased equipment should no longer be considered a non-recurring expense, and accordingly, loss on disposal of leased equipment is now reflected within non-GAAP gross margins and adjusted loss from operations.

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EBITDA AND NET PROFIT MARGIN TO ADJUSTED EBITDA MARGIN

    (In thousands)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income (loss)

    $

    10,882

     

     

    $

    (15,720

    )

     

    $

    (33,138

    )

     

    $

    (54,017

    )

    Depreciation and amortization

     

    6,481

     

     

     

    5,442

     

     

     

    24,340

     

     

     

    17,375

     

    Stock-based compensation

     

    5,280

     

     

     

    3,392

     

     

     

    21,096

     

     

     

    24,756

     

    Interest expense (income)

     

    531

     

     

     

    (548

    )

     

     

    196

     

     

     

    (2,942

    )

    Provision for income taxes

     

    —

     

     

     

    —

     

     

     

    62

     

     

     

    —

     

    Change in fair value of contingent earn-out liability

     

    (10,138

    )

     

     

    (1,218

    )

     

     

    (12,435

    )

     

     

    (16,310

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (2,683

    )

     

     

    (311

    )

     

     

    (2,614

    )

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    (6,595

    )

     

     

    (1,131

    )

     

     

    (435

    )

     

     

    (6,592

    )

    Loss on impairment of leased equipment

     

    —

     

     

     

    15

     

     

     

    —

     

     

     

    224

     

    Loss on impairment of intangible asset

     

    —

     

     

     

    983

     

     

     

    —

     

     

     

    983

     

    Loss on disposal of leased equipment

     

    284

     

     

     

    —

     

     

     

    3,787

     

     

     

    —

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,060

     

     

     

    2,976

     

     

     

    3,060

     

    Non-recurring inventory charges

     

    —

     

     

     

    123

     

     

     

    —

     

     

     

    2,730

     

    Other non-recurring legal and regulatory costs

     

    (2,225

    )

     

     

    7,284

     

     

     

    7,279

     

     

     

    12,284

     

    Adjusted EBITDA

    $

    1,817

     

     

    $

    371

     

     

    $

    11,114

     

     

    $

    (20,978

    )

     

     

     

     

     

     

     

     

    Net profit margin %

     

    28.3

    %

     

     

    (54.0

    )%

     

     

    (22.7

    )%

     

     

    (52.0

    )%

    Impact of adjustments from Net loss to Adjusted EBITDA

     

    (23.6

    )%

     

     

    55.3

    %

     

     

    30.3

    %

     

     

    31.8

    %

    Adjusted EBITDA margin %

     

    4.7

    %

     

     

    1.3

    %

     

     

    7.6

    %

     

     

    (20.2

    )%

     

    EVOLV TECHNOLOGY

    RECONCILIATION OF GAAP NET INCOME (LOSS) TO ADJUSTED EARNINGS (LOSS)

    (In thousands, except share and per share data)

    (Unaudited)

     

     

    Three Months Ended

    December 31,

     

    Twelve Months Ended

    December 31,

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income (loss)

    $

    10,882

     

     

    $

    (15,720

    )

     

    $

    (33,138

    )

     

    $

    (54,017

    )

    Stock-based compensation

     

    5,280

     

     

     

    3,392

     

     

     

    21,096

     

     

     

    24,756

     

    Amortization of capitalized stock-based compensation

     

    150

     

     

     

    85

     

     

     

    474

     

     

     

    137

     

    Change in fair value of contingent earn-out liability

     

    (10,138

    )

     

     

    (1,218

    )

     

     

    (12,435

    )

     

     

    (16,310

    )

    Change in fair value of contingently issuable/returnable common stock liability/asset

     

    (2,683

    )

     

     

    (311

    )

     

     

    (2,614

    )

     

     

    (2,529

    )

    Change in fair value of public warrant liability

     

    (6,595

    )

     

     

    (1,131

    )

     

     

    (435

    )

     

     

    (6,592

    )

    Loss on impairment of leased equipment

     

    —

     

     

     

    15

     

     

     

    —

     

     

     

    224

     

    Loss on impairment of intangible asset

     

    —

     

     

     

    983

     

     

     

    —

     

     

     

    983

     

    Non-recurring employee restructuring and other separation costs

     

    —

     

     

     

    2,060

     

     

     

    2,976

     

     

     

    3,060

     

    Non-recurring inventory charges

     

    —

     

     

     

    123

     

     

     

    —

     

     

     

    2,730

     

    Other non-recurring legal and regulatory costs

     

    (2,225

    )

     

     

    7,284

     

     

     

    7,279

     

     

     

    12,284

     

    Adjusted loss

    $

    (5,329

    )

     

    $

    (4,438

    )

     

    $

    (16,797

    )

     

    $

    (35,274

    )

     

     

     

     

     

     

     

     

    Weighted average common shares outstanding – diluted

     

    174,625,931

     

     

     

    158,997,410

     

     

     

    168,419,211

     

     

     

    156,573,886

     

     

     

     

     

     

     

     

     

    Adjusted loss per share – diluted

    $

    (0.03

    )

     

    $

    (0.03

    )

     

    $

    (0.10

    )

     

    $

    (0.23

    )

    *Stock-based compensation, amortization of capitalized stock-based compensation, and non-recurring restructuring and other employee separation costs were recorded in the condensed consolidated statements of operations and comprehensive loss (income) as follows. Prior period amounts are being shown for comparative purposes:

     

    Three Months Ended,

     

    March 31,

    2024

     

    June 30,

    2024

     

    September 30,

    2024

     

    December 31,

    2024

     

    March 31,

    2025

     

    June 30,

    2025

     

    September 30,

    2025

     

    December 31,

    2025

    Stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of product revenue

    $

    —

     

    $

    5

     

    $

    4

     

    $

    8

     

     

    $

    8

     

    $

    17

     

    $

    32

     

    $

    39

    Cost of subscription revenue

     

    91

     

     

    110

     

     

    169

     

     

    154

     

     

     

    137

     

     

    167

     

     

    146

     

     

    135

    Cost of service revenue

     

    44

     

     

    51

     

     

    63

     

     

    61

     

     

     

    67

     

     

    74

     

     

    72

     

     

    80

    Cost of license fee and other revenue

     

    3

     

     

    7

     

     

    8

     

     

    10

     

     

     

    7

     

     

    24

     

     

    19

     

     

    20

    Research and development

     

    902

     

     

    1,222

     

     

    1,243

     

     

    1,153

     

     

     

    1,115

     

     

    1,154

     

     

    1,227

     

     

    1,252

    Sales and marketing

     

    2,959

     

     

    2,724

     

     

    2,516

     

     

    2,747

     

     

     

    1,048

     

     

    1,710

     

     

    1,480

     

     

    1,330

    General and administrative

     

    2,431

     

     

    3,308

     

     

    3,504

     

     

    (741

    )

     

     

    1,972

     

     

    2,401

     

     

    2,414

     

     

    2,424

    Restructuring costs

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

     

    525

     

     

    —

     

     

    —

     

    —

    Total stock-based compensation

    $

    6,430

     

    $

    7,427

     

    $

    7,507

     

    $

    3,392

     

     

    $

    4,879

     

    $

    5,547

     

    $

    5,390

     

    $

    5,280

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Amortization of capitalized stock-based compensation:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of subscription revenue

    $

    8

     

    $

    8

     

    $

    13

     

    $

    47

     

     

    $

    59

     

    $

    60

     

    $

    63

     

    $

    82

    Cost of service revenue

     

    6

     

     

    7

     

     

    10

     

     

    38

     

     

     

    44

     

     

    47

     

     

    51

     

     

    68

    Total amortization of capitalized stock-based compensation

    $

    14

     

    $

    15

     

    $

    23

     

    $

    85

     

     

    $

    103

     

    $

    107

     

    $

    114

     

    $

    150

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Non-recurring employee restructuring and other separation costs:

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    Cost of service revenue

    $

    —

     

    $

    —

     

    $

    —

     

    $

    —

     

     

    $

    —

     

    $

    6

     

    $

    —

     

    $

    —

    Research and development

     

    —

     

     

    —

     

     

    —

     

     

    —

     

     

     

    —

     

     

    31

     

     

    —

     

     

    —

    Sales and marketing

     

    —

     

     

    140

     

     

    —

     

     

    63

     

     

     

    —

     

     

    613

     

    6

     

    —

    General and administrative

     

    —

     

     

    —

     

     

    —

     

     

    1,997

     

     

     

    —

     

     

    183

     

     

    —

     

     

    —

    Restructuring costs

     

    —

     

     

    860

     

     

    —

     

     

    —

     

     

     

    2,137

     

     

    —

     

     

    —

     

     

    —

    Total non-recurring employee restructuring and other separation costs

    $

    —

     

    $

    1,000

     

    $

    —

     

    $

    2,060

     

     

    $

    2,137

     

    $

    833

     

    $

    6

     

    $

    —

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20260310341542/en/

    Investor Relations:

    Brian Norris

    Senior Vice President of Finance and Investor Relations

    [email protected]

    Get the next $EVLV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $EVLV

    DatePrice TargetRatingAnalyst
    8/15/2025$9.00Hold → Buy
    Lake Street
    8/15/2025$10.00Buy
    TD Cowen
    5/21/2025$7.50Market Perform → Outperform
    Northland Capital
    10/28/2024Outperform → Market Perform
    Northland Capital
    5/20/2024$8.50 → $5.75Buy
    Craig Hallum
    5/10/2024$6.00 → $3.50Buy → Hold
    Lake Street
    11/21/2023$6.00Buy
    Lake Street
    4/28/2023$6.00Buy
    Craig Hallum
    More analyst ratings

    $EVLV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Ellenbogen Michael sold $468,032 worth of shares (91,771 units at $5.10), decreasing direct ownership by 4% to 2,083,961 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    3/9/26 4:07:25 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form 4 filed by President & CEO Kedzierski John

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    3/4/26 4:03:57 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form 4 filed by Chief Revenue Officer Marshall Robert E

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    3/4/26 4:03:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    SEC Filings

    View All

    SEC Form 10-K filed by Evolv Technologies Holdings Inc.

    10-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    3/10/26 4:09:34 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Evolv Technologies Holdings, Inc. (0001805385) (Filer)

    3/10/26 4:07:29 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    SEC Form 144 filed by Evolv Technologies Holdings Inc.

    144 - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    3/6/26 4:03:40 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evolv Technologies Holdings upgraded by Lake Street with a new price target

    Lake Street upgraded Evolv Technologies Holdings from Hold to Buy and set a new price target of $9.00

    8/15/25 8:30:18 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    TD Cowen resumed coverage on Evolv Technologies Holdings with a new price target

    TD Cowen resumed coverage of Evolv Technologies Holdings with a rating of Buy and set a new price target of $10.00

    8/15/25 8:18:59 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technologies Holdings upgraded by Northland Capital with a new price target

    Northland Capital upgraded Evolv Technologies Holdings from Market Perform to Outperform and set a new price target of $7.50

    5/21/25 8:40:06 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Revenue Officer Marshall Robert E bought $42,420 worth of shares (7,000 units at $6.06) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/25/25 4:03:38 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Charlton Kevin M. bought $85,196 worth of shares (15,000 units at $5.68) (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/21/25 4:39:17 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Director Shapiro Richard A bought $278,126 worth of shares (46,300 units at $6.01), increasing direct ownership by 133% to 52,515 units (SEC Form 4)

    4 - Evolv Technologies Holdings, Inc. (0001805385) (Issuer)

    11/20/25 4:20:48 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evolv Technology Reports Fourth Quarter Financial Results

    — Company Raises Outlook for 2026 —  Q4'25 Revenue of $38.5 million, up 32% year-over-year Q4'25 Ending ARR1 of $120.5 million, up 21% year-over-year Q4'25 Net Income of $10.9 million, with Net Profit Margin of 28% Q4'25 Adjusted EBITDA2 of $1.8 million, with Adjusted EBITDA Margin2 of 5% Q4'25 Ending Cash, Cash Equivalents and Marketable Securities of $69.0 million, up $12.8 million sequentially Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the year ended December 31, 2025. "We are pleased to be reporting solid fourth qua

    3/10/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Host Investor Day on June 9, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that it will host Evolv Technology Investor Day 2026 on Tuesday, June 9, 2026 from 9:00 a.m. to 12:00 p.m. Eastern Time. Members of the Company's management team will provide an overview of the Company's vision, strategy, growth initiatives, business trends, products and technology as well as its financial goals. Evolv Technology Investor Day 2026 will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect p

    3/10/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Surpasses Four Billion People Screened Worldwide, Screening More People Per Day than the TSA in 2025

    For decades, security screening forced a tradeoff: stronger protection meant slower lines, intrusive searches, and frustrated visitors. Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, set out to challenge that assumption — and in doing so, fundamentally changed how millions of people experience security. Since launching Evolv Express® in 2019, Evolv has pioneered a modern approach to weapons screening that provides strong weapons detection capabilities balanced with visitor experience. By combining advanced sensor technology with unique data and proprietary artificial intelligence, E

    3/9/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Financials

    Live finance-specific insights

    View All

    Evolv Technology Reports Fourth Quarter Financial Results

    — Company Raises Outlook for 2026 —  Q4'25 Revenue of $38.5 million, up 32% year-over-year Q4'25 Ending ARR1 of $120.5 million, up 21% year-over-year Q4'25 Net Income of $10.9 million, with Net Profit Margin of 28% Q4'25 Adjusted EBITDA2 of $1.8 million, with Adjusted EBITDA Margin2 of 5% Q4'25 Ending Cash, Cash Equivalents and Marketable Securities of $69.0 million, up $12.8 million sequentially Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the year ended December 31, 2025. "We are pleased to be reporting solid fourth qua

    3/10/26 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology to Release Fourth Quarter Financial Results on March 10, 2026

    Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced that the Company will release financial results for the fourth quarter of 2025 on Tuesday, March 10, 2026, after the market closes. Members of the Company's management team plan to host a live webcast at 4:30 p.m. Eastern Time on that day to discuss the financial results as well as management's outlook for the business. The conference call will be webcast live at http://ir.evolvtechnology.com. About Evolv Technology Evolv (NASDAQ:EVLV) is designed to transform human security by helping organizations detect potential

    2/2/26 8:00:00 AM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Evolv Technology Reports Third Quarter Financial Results

    — Company Raises Revenue Outlook for 2025 to $142-$145 Million, up 37%-40% Year-Over-Year — Q3'25 Revenue of $42.9 million, up 57% year-over-year Q3'25 Ending ARR1 of $117.2 million, up 25% year-over-year Q3'25 Net Loss of $(1.8) million, with Net Profit Margin of (4)% Q3'25 Adjusted EBITDA2 of $5.1 million, with Adjusted EBITDA Margin2 of 12% Evolv Technologies Holdings, Inc (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to help create safer experiences, today announced financial results for the quarter ended September 30, 2025. "We made meaningful progress across many key measures of the business in the third quarter—including

    11/13/25 4:05:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    12/12/24 3:21:41 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/12/24 2:31:40 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    Amendment: SEC Form SC 13G/A filed by Evolv Technologies Holdings Inc.

    SC 13G/A - Evolv Technologies Holdings, Inc. (0001805385) (Subject)

    11/7/24 4:31:46 PM ET
    $EVLV
    Computer peripheral equipment
    Technology

    $EVLV
    Leadership Updates

    Live Leadership Updates

    View All

    Evolv Technology Announces the Appointment of Henrik Kühl as a New Independent Director

    – Long-Time Member of the Board of Directors and Early Venture Capitalist Bilal Zuberi Resigns from Board – Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced the appointment of Mr. Henrik Kühl, age 46, to its Board of Directors ("Board") effective February 12, 2026. Kühl will also serve on the Board's Audit Committee. The Board affirmatively determined that Kühl is independent and an audit committee financial expert as that term is defined by applicable Securities and Exchange Commission regulations. Kühl is an accomplished leader with over 25 years of experience in c

    2/12/26 8:00:00 AM ET
    $AXON
    $EVLV
    Ordnance And Accessories
    Industrials
    Computer peripheral equipment
    Technology

    TransAct Appoints Dana Loof as Chief Marketing Officer to Accelerate Growth and Platform Expansion

    TransAct Technologies Incorporated (NASDAQ:TACT) ("TransAct" or the "Company"), a global leader in software-driven technology and integrated printing solutions, today announced the appointment of Dana Loof as Chief Marketing Officer. Ms. Loof will lead TransAct's global marketing organization, with a mandate to strengthen brand leadership, sharpen go-to-market execution, and accelerate adoption of the Company's growing technology portfolio. Ms. Loof has a 30-year track record leading high-growth technology companies, where she has been responsible for global marketing strategy, brand strategy and positioning, category building, revenue generation, and customer engagement initiatives. In h

    1/20/26 4:05:00 PM ET
    $EVLV
    $TACT
    Computer peripheral equipment
    Technology

    Evolv Extends Partnership with New England Patriots, New England Revolution, and Gillette Stadium

    Extension of original 2021 agreement includes expansion of Evolv Express subscription, and official partnership designations Evolv Technologies Holdings, Inc. (NASDAQ:EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that it renewed its partnership with Gillette Stadium, home of the New England Patriots and New England Revolution. The renewal, which extends a partnership initiated in 2021, increases the number of entry points at which Evolv Express® security screening will be used. All members of the public entering the stadium for football games, soccer matches, concerts, and other events will pass through an

    9/16/25 12:00:00 PM ET
    $EVLV
    Computer peripheral equipment
    Technology